Lungpacer Medical Inc. is the most recent company to be accepted into FDA’s Expedited Access Pathway (EAP), a year-old program intended to give innovative devices a regulatory leg-up to speed the pa
Out of the Blocks Summarizing the technologies of recently founded companies Acton Pharmaceuticals Inc. 225 Cedar Hill Street Suite 337 Marlborough, MA 01752 Phone: (508) 624-8733 E-Mail: dkreisler@ac